Blood, saliva tests help predict HPV-linked HNC recurrence
August 26, 2014 -- Blood and saliva tests can accurately predict the recurrence of human papillomavirus (HPV)-linked head and neck cancers (HNC), according to a recent study in JAMA Otolaryngology -- Head & Neck Surgery. Finding HPV DNA in both blood and saliva samples after treatment accurately predicted recurrence 70% of the time.
New hope for patients with hard-to-treat head and neck cancers
August 20, 2014 -- Using a technique that looks for genes that tumor cells need to survive, Seattle researchers have identified a potential new drug target for a class of difficult-to-treat head and neck cancers, according to a new study in Clinical Cancer Research.
New imaging agent helps find, remove cancer
August 19, 2014 -- Ohio researchers are developing a hybrid imaging agent that makes cancer cells "light up" during surgery. Designed around a peptide called HN1, it has such an affinity for head and neck cancer cells that it's been called a "head and neck cancer homing device."
LSU cancer center offers molecular profiling program
August 19, 2014 -- Louisiana State University's (LSU) Health Shreveport Feist-Weiller Cancer Center now offers access to an innovative, precision-medicine technology that determines the unique biological characteristics of each patient's cancer tumor.
Study: Editing HPV's genes kills cancer cells
August 14, 2014 -- Researchers have hijacked a defense system normally used by bacteria to fend off viral infections and redirected it against human papillomavirus (HPV), the virus that causes cervical, head and neck, and other cancers, according to a new study in the Journal of Virology.
'Shape-shifting' material could help reconstruct faces
August 13, 2014 -- SAN FRANCISCO - A new material that changes shape on heating could help heal bone lesions caused by injuries, tumor removal, or birth defects such as cleft palates, according to research presented at this week's American Chemical Society meeting.
PET may artificially boost HNC survival rates
August 11, 2014 -- The use of positron emission tomography (PET) is associated with a stage migration phenomenon in locally advanced head and neck cancer (HNC) patients, according to a recent report in JAMA Otolaryngology -- Head & Neck Surgery.
Study: Genetic mutations linked to salivary gland tumors
August 8, 2014 -- Scientists from the Scripps Research Institute in Florida have found genetic mutations linked to salivary gland tumors, according to a new study in Proceedings of the National Academy of Sciences. The discovery could help develop new treatments that target the cancer's underlying genetic causes.
Aspirin can help battle head/neck cancer
Aspirin appears to offer significant protection against head and neck (HNC) cancer, according to a study in the British Journal of Cancer. Regular aspirin use was associated with a 22% reduction in HNC and seems to be particularly effective in preventing laryngeal cancer.